Aleafia Health increases strategic investment in Australian LP

Twitter icon

Read entire article here.

Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has increased its strategic investment in CannaPacific Pty. Limited (“CannaPacific”), a medical cannabis company that is federally licensed to cultivate and research cannabis in Australia.

Aleafia Health further invested AU$540,000 in ordinary shares of CannaPacific in connection with CannaPacific’s AU$4,500,000 capital financing.

The strategic investment immediately follows the closing of CannaPacific’s acquisition of a 108,000 sq. ft. greenhouse located in the iconic Byron Bay region of New South Wales, Australia. The greenhouse facility will be used for cannabis cultivation grown for eventual sale to medical patients and global export. CannaPacific’s management is composed of veterans of medicine, pharmaceutical manufacturing and sales, oncology, hospital management, plant science and cannabis cultivation.

CannaPacific also intends to leverage Aleafia Health’s global cannabis health and wellness ecosystem across the Company’s four divisions:

Aleafia Campus: Starter plant material (pending regulatory approval) and facility build-out expertise to accelerate cannabis cultivation
Health & Wellness Clinics: Medical clinic expertise, including access to Electronic Medical Record (EMR) systems along with physician and patient recruitment
FoliEdge Academy: Access to the Company’s proprietary online cannabis education platform developed with unique courses developed for physicians, patients, employers and healthcare institutions
eCommerce Consumer Marketplace: Access to Aleafia Health’s soon to be launched proprietary cannabis consumer experience marketplace, built for global scale with multi-jurisdiction compliance, multi-language and multi-currency

“With an experienced management team, major cultivation assets, along with Aleafia Health’s cross platform expertise in clinic operations, product development and online sales, CannaPacific is poised to seize on its early mover advantage in the Australian medical cannabis market,” said Aleafia Health CEO Geoffrey Benic.

“We are delighted to have Aleafia Health as a strategic investor,” said CannaPacific CEO Joshua Dennis. “With the closing of our 108,000 sq. ft. greenhouse facility and strategic relationship with a medical cannabis leader, we expect to accelerate our first to market strategy in Australia along with our objective of becoming a major exporter of medical cannabis products.”

Read entire article here.

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Article category: 
Regional Marijuana News: